Arabic Arabic English English French French German German

Identification of Medicinal Products: Path to Global Implementation

FDA presents updates on the Identification of Medicinal Products (IDMP) standards development and implementation with an emphasis on international collaboration, pilot projects on substance, dosage form and pharmaceutical identification (PhPID). Also discussed is the Global Substance Registration System (GSRS) and EU Substance Registration System (SRS).
Learn more at:
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  

Upcoming Training –   
SBIA Listserv –
SBIA 2021 Playlist –
SBIA LinkedIn –  
SBIA Training Resources –  
Twitter –  
Email –  
Phone – (301) 796-6707 I (866) 405-5367

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Consumer Updates: Health and Safety Information You Need

Next Post

Public Meeting: Patient-Focused Drug Development for Fibromyalgia (Part 1 of 2)

Related Posts